Since news broke last year that medical device maker DePuy Orthopedics had ordered a secret DePuy Attune knee recall, the company has been trying to combat a series of negative reports and hundreds of consumer lawsuits by those needing revision surgery.
This Spring, Johnson & Johnson subsidiary DePuy Synthes Orthopedics announced the launch of the new Attune Revision Knee System, a secondary replacement designed for those patients who’ve experienced failure of their primary knee implant.
The rate of knee replacement surgeries each year in the United States has tripled in recent decades to almost 750,000 annually, and the number is expected to continue growing to roughly 3.5 million procedures over the next decade.
In June, details emerged that DePuy’s Attune knee implant system, one of the most popular on the market, was experiencing higher-than-expected failure rates among patients.
In recent months, orthopedic device maker Stryker has warned doctors that several models of its metal hip implants may be defective, causing device separation, failure and the need for revision surgery.
This was followed by a mandatory Stryker hip recall in Canada last September due to a higher than expected number of patient complaints.